Literature DB >> 18574360

Individual differences in opioid efficacy for chronic noncancer pain.

Joseph L Riley1, Barbara A Hastie.   

Abstract

OBJECTIVE: Over a decade ago, Jamison noted the lack of studies that identify patient profiles or specific groups that might be best suited for opioid treatment of chronic noncancer pain.
METHODS: This paper reviews the studies that provide evidence for individual differences in opioid analgesia for chronic noncancer pain.
RESULTS: What we have found is that few investigations have addressed these important aspects of pain treatment. The most consistent finding is that depression and anxiety are associated with increased risk for drug abuse and decreased opioid efficacy. DISCUSSION: The question remains whether the psychologic disorders antedated the pain condition or whether the experience of chronic pain exerts psychologic pressures that cause changes in behavior and psychologic processes. Additionally, the overall pattern suggests that younger age is predictive of opioid abuse and greater opioid efficacy. We also present a brief review of biologic mechanisms that support individual differences on opioid analgesia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18574360     DOI: 10.1097/AJP.0b013e31816c6654

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  5 in total

1.  Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.

Authors:  Meldon Kahan; Lynn Wilson; Angela Mailis-Gagnon; Anita Srivastava
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

2.  Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative Affect.

Authors:  R R Edwards; A J Dolman; E Michna; J N Katz; S S Nedeljkovic; D Janfaza; Z Isaac; M O Martel; R N Jamison; A D Wasan
Journal:  Pain Med       Date:  2016-03-01       Impact factor: 3.750

3.  Effectiveness of long-term opioid therapy among chronic non-cancer pain patients attending multidisciplinary pain treatment clinics: A Quebec Pain Registry study.

Authors:  Hichem Saïdi; M Gabrielle Pagé; Aline Boulanger; Mark A Ware; Manon Choinière
Journal:  Can J Pain       Date:  2018-04-19

4.  An Investigation into Proteomic Constituents of Cerebrospinal Fluid in Patients with Chronic Peripheral Neuropathic Pain Medicated with Opioids- a Pilot Study.

Authors:  Jonathan Royds; Hilary Cassidy; Melissa J Conroy; Margaret R Dunne; David Matallanas; Joanne Lysaght; Connail McCrory
Journal:  J Neuroimmune Pharmacol       Date:  2020-11-20       Impact factor: 4.147

5.  CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications.

Authors:  Jennifer L St Sauver; Janet E Olson; Veronique L Roger; Wayne T Nicholson; John L Black; Paul Y Takahashi; Pedro J Caraballo; Elizabeth J Bell; Debra J Jacobson; Nicholas B Larson; Suzette J Bielinski
Journal:  Pharmgenomics Pers Med       Date:  2017-07-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.